A World Cancer Day edition of the podcast, with Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, J&J.

The team are joined by Charl van Zyl, President and CEO, Lundbeck Pharmaceuticals, to discuss advances in the treatment of neurological disorders.

Curious to know could happen in the industry in 2025? Join us as we talk to three guests about their top predictions for the year ahead.

Look back at the key moments from the past year in pharma with three of our former guests, as they highlight key trends, challenges and more.

Find out how to normalise the conversation, not the suffering, around menopause with Dr Cecilia Caetano, Vice President, Women’s Health, Bayer.

Season 8 is almost over, but before we release our finale episode, why not take a listen to some of our favourite moments from the series just gone?

Elias Revonta, Founder & CEO, Orcason Medical, joins the podcast to discuss why the fight against AMR needs to extend beyond awareness weeks.

Patrick Oliver, General Manager for the UK and Ireland at Alfasigma explores the company’s exciting entry into the UK market and the evolving healthcare landscape in the country.